• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低相对分子质量岩藻聚糖硫酸酯提取物对 HT1080 纤维肉瘤细胞生长和程序性死亡配体 1 表达的选择性抑制。

Selective Suppression of Cell Growth and Programmed Cell Death-Ligand 1 Expression in HT1080 Fibrosarcoma Cells by Low Molecular Weight Fucoidan Extract.

机构信息

Faculty of Agriculture, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.

Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.

出版信息

Mar Drugs. 2019 Jul 19;17(7):421. doi: 10.3390/md17070421.

DOI:10.3390/md17070421
PMID:31331053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6669552/
Abstract

Low molecular weight fucoidan extract (LMF), prepared by an abalone glycosidase digestion of a crude fucoidan extracted from Kylin, exhibits various biological activities, including anticancer effect. Various cancers express programmed cell death-ligand 1 (PD-L1), which is known to play a significant role in evasion of the host immune surveillance system. PD-L1 is also expressed in many types of normal cells for self-protection. Previous research has revealed that selective inhibition of PD-L1 expressed in cancer cells is critical for successful cancer eradication. In the present study, we analyzed whether LMF could regulate PD-L1 expression in HT1080 fibrosarcoma cells. Our results demonstrated that LMF suppressed PD-L1/PD-L2 expression and the growth of HT1080 cancer cells and had no effect on the growth of normal TIG-1 cells. Thus, LMF differentially regulates PD-L1 expression in normal and cancer cells and could serve as an alternative complementary agent for treatment of cancers with high PD-L1 expression.

摘要

低分子量褐藻糖胶提取物(LMF)是通过鲍鱼糖苷酶消化从麒麟中提取的粗褐藻糖胶制备而成的,具有多种生物活性,包括抗癌作用。各种癌症都表达程序性细胞死亡配体 1(PD-L1),PD-L1 已知在逃避宿主免疫监视系统中发挥重要作用。PD-L1 也在许多类型的正常细胞中表达以进行自我保护。先前的研究表明,选择性抑制癌细胞中表达的 PD-L1 对于成功消除癌症至关重要。在本研究中,我们分析了 LMF 是否可以调节 HT1080 纤维肉瘤细胞中的 PD-L1 表达。我们的结果表明,LMF 抑制 PD-L1/PD-L2 表达和 HT1080 癌细胞的生长,对正常 TIG-1 细胞的生长没有影响。因此,LMF 可在正常和癌细胞中差异调节 PD-L1 的表达,可作为治疗高 PD-L1 表达癌症的替代补充剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/dae60060735f/marinedrugs-17-00421-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/56b98712cc9f/marinedrugs-17-00421-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/5fc32338ed0a/marinedrugs-17-00421-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/b2c7f6cc846f/marinedrugs-17-00421-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/ac3c1d1f5963/marinedrugs-17-00421-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/143df00b9d3e/marinedrugs-17-00421-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/39f12b1b0c77/marinedrugs-17-00421-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/8e70582cefc0/marinedrugs-17-00421-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/08b0246861b6/marinedrugs-17-00421-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/2d08bb20ec0b/marinedrugs-17-00421-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/d2ce3134e2e1/marinedrugs-17-00421-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/dae60060735f/marinedrugs-17-00421-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/56b98712cc9f/marinedrugs-17-00421-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/5fc32338ed0a/marinedrugs-17-00421-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/b2c7f6cc846f/marinedrugs-17-00421-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/ac3c1d1f5963/marinedrugs-17-00421-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/143df00b9d3e/marinedrugs-17-00421-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/39f12b1b0c77/marinedrugs-17-00421-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/8e70582cefc0/marinedrugs-17-00421-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/08b0246861b6/marinedrugs-17-00421-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/2d08bb20ec0b/marinedrugs-17-00421-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/d2ce3134e2e1/marinedrugs-17-00421-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804a/6669552/dae60060735f/marinedrugs-17-00421-g011.jpg

相似文献

1
Selective Suppression of Cell Growth and Programmed Cell Death-Ligand 1 Expression in HT1080 Fibrosarcoma Cells by Low Molecular Weight Fucoidan Extract.低相对分子质量岩藻聚糖硫酸酯提取物对 HT1080 纤维肉瘤细胞生长和程序性死亡配体 1 表达的选择性抑制。
Mar Drugs. 2019 Jul 19;17(7):421. doi: 10.3390/md17070421.
2
Enzyme-digested Fucoidan Extracts Derived from Seaweed Mozuku of Cladosiphon novae-caledoniae kylin Inhibit Invasion and Angiogenesis of Tumor Cells.酶解麒麟菜褐藻糖胶提取物抑制肿瘤细胞的侵袭和血管生成。
Cytotechnology. 2005 Jan;47(1-3):117-26. doi: 10.1007/s10616-005-3761-8.
3
Anti-Proliferative and Pro-Apoptotic vLMW Fucoidan Formulas Decrease PD-L1 Surface Expression in EBV Latency III and DLBCL Tumoral B-Cells by Decreasing Actin Network.抗增殖和促凋亡的低分子量岩藻聚糖硫酸酯配方通过降低肌动蛋白网络降低 EBV 潜伏期 III 和 DLBCL 肿瘤 B 细胞中的 PD-L1 表面表达。
Mar Drugs. 2023 Feb 18;21(2):132. doi: 10.3390/md21020132.
4
Anticancer Activities of Hesperidin via Suppression of Up-Regulated Programmed Death-Ligand 1 Expression in Oral Cancer Cells.橙皮苷通过抑制口腔癌细胞程序性死亡配体 1 的上调表达发挥抗癌活性。
Molecules. 2021 Sep 2;26(17):5345. doi: 10.3390/molecules26175345.
5
Oligo-Fucoidan supplementation enhances the effect of Olaparib on preventing metastasis and recurrence of triple-negative breast cancer in mice.寡聚岩藻糖醛酸酯补充剂增强奥拉帕利对预防三阴性乳腺癌转移和复发的作用。
J Biomed Sci. 2022 Sep 15;29(1):70. doi: 10.1186/s12929-022-00855-6.
6
Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy.设计、合成及评估 PD-L1 肽拮抗剂作为癌症免疫治疗的新型药物。
Bioorg Med Chem. 2021 Jan 15;30:115951. doi: 10.1016/j.bmc.2020.115951. Epub 2020 Dec 15.
7
The extracts of overcome tumor immune tolerance by inhibition of tumor programmed cell death protein ligand-1 expression.通过抑制肿瘤程序性死亡配体-1 的表达来克服肿瘤免疫耐受的提取物。
Int J Med Sci. 2020 Mar 26;17(7):939-945. doi: 10.7150/ijms.42978. eCollection 2020.
8
Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in MDA-MB-231 and MCF-7 breast cancer cells.岩藻聚糖硫酸酯提取物增强了化疗药物在 MDA-MB-231 和 MCF-7 乳腺癌细胞中的抗癌活性。
Mar Drugs. 2013 Jan 9;11(1):81-98. doi: 10.3390/md11010081.
9
Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody.灵芝破壁孢子水提取物通过下调 PD-L1 抗体效率增强了 pd-l1 抗体的效率,并缓解了 pd-l1 单克隆抗体的并发症。
Biomed Pharmacother. 2020 Nov;131:110541. doi: 10.1016/j.biopha.2020.110541. Epub 2020 Sep 18.
10
Elucidation of S-Allylcysteine Role in Inducing Apoptosis by Inhibiting PD-L1 Expression in Human Lung Cancer Cells.阐明 S-烯丙半胱氨酸通过抑制人肺癌细胞中 PD-L1 表达诱导细胞凋亡的作用。
Anticancer Agents Med Chem. 2021;21(4):532-541. doi: 10.2174/1871520620666200728121929.

引用本文的文献

1
Efficacy of Xiaoyao-san preparations in treating Hashimoto's thyroiditis: a meta-analysis and systematic review.逍遥散制剂治疗桥本甲状腺炎的疗效:一项荟萃分析与系统评价
Front Pharmacol. 2025 Jun 13;16:1528506. doi: 10.3389/fphar.2025.1528506. eCollection 2025.
2
Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy.PD-1/PD-L1信号轴在肿瘤发生中的作用及其被生物活性天然化合物靶向用于癌症免疫治疗的研究
Mil Med Res. 2024 Dec 18;11(1):82. doi: 10.1186/s40779-024-00586-9.
3
Low-molecular-weight fucoidan inhibits the proliferation of melanoma via Bcl-2 phosphorylation and PTEN/AKT pathway.

本文引用的文献

1
Structural elucidation of fucoidan from Cladosiphon okamuranus (Okinawa mozuku).从 Okamuranus 角叉菜(冲绳海蕴)中分离得到的岩藻聚糖的结构解析。
Food Chem. 2019 Jan 30;272:222-226. doi: 10.1016/j.foodchem.2018.08.034. Epub 2018 Aug 9.
2
Combination Immunotherapy in Non-small Cell Lung Cancer.非小细胞肺癌的免疫联合治疗。
Curr Oncol Rep. 2018 May 8;20(7):55. doi: 10.1007/s11912-018-0697-7.
3
RhoB: Team Oncogene or Team Tumor Suppressor?RhoB:致癌基因阵营还是肿瘤抑制基因阵营?
低分子量岩藻聚糖硫酸酯通过 Bcl-2 磷酸化和 PTEN/AKT 通路抑制黑色素瘤的增殖。
Oncol Res. 2023 Dec 28;32(2):273-282. doi: 10.32604/or.2023.044362. eCollection 2023.
4
Unveiling the anti-glioma potential of a marine derivative, Fucoidan: its synergistic cytotoxicity with Temozolomide-an in vitro and in silico experimental study.揭示海洋衍生物岩藻依聚糖的抗胶质瘤潜力:其与替莫唑胺的协同细胞毒性——一项体外和计算机模拟实验研究
3 Biotech. 2023 Dec;13(12):397. doi: 10.1007/s13205-023-03814-6. Epub 2023 Nov 14.
5
Anti-Proliferative and Pro-Apoptotic vLMW Fucoidan Formulas Decrease PD-L1 Surface Expression in EBV Latency III and DLBCL Tumoral B-Cells by Decreasing Actin Network.抗增殖和促凋亡的低分子量岩藻聚糖硫酸酯配方通过降低肌动蛋白网络降低 EBV 潜伏期 III 和 DLBCL 肿瘤 B 细胞中的 PD-L1 表面表达。
Mar Drugs. 2023 Feb 18;21(2):132. doi: 10.3390/md21020132.
6
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation.通过联合治疗和 PD-L1 调控提高 PD-1/PD-L1 阻断的抗癌疗效。
J Hematol Oncol. 2022 Mar 12;15(1):24. doi: 10.1186/s13045-022-01242-2.
7
Development of a Bispecific Antibody-Based Platform for Retargeting of Capsid Modified AAV Vectors.基于双特异性抗体的平台用于重新靶向衣壳修饰的 AAV 载体的开发。
Int J Mol Sci. 2021 Aug 3;22(15):8355. doi: 10.3390/ijms22158355.
8
Marine Compounds and Cancer: Updates 2020.海洋化合物与癌症:2020 年最新进展
Mar Drugs. 2020 Dec 15;18(12):643. doi: 10.3390/md18120643.
9
Therapies from Fucoidan: New Developments.岩藻聚糖硫酸酯的治疗作用:新进展。
Mar Drugs. 2019 Oct 9;17(10):571. doi: 10.3390/md17100571.
Genes (Basel). 2018 Jan 30;9(2):67. doi: 10.3390/genes9020067.
4
Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions.表皮生长因子受体突变型非小细胞肺癌的免疫检查点抑制剂:当前的争议和未来的方向。
Lung Cancer. 2018 Jan;115:12-20. doi: 10.1016/j.lungcan.2017.11.009. Epub 2017 Nov 13.
5
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.致癌性RAS信号通过稳定PD-L1 mRNA促进肿瘤免疫抗性。
Immunity. 2017 Dec 19;47(6):1083-1099.e6. doi: 10.1016/j.immuni.2017.11.016. Epub 2017 Dec 12.
6
Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression.寡聚岩藻聚糖可抑制 IL-6 和 CCL2 的产生,并与 p53 合作抑制 ATM 信号通路和肿瘤进展。
Sci Rep. 2017 Sep 19;7(1):11864. doi: 10.1038/s41598-017-12111-1.
7
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome.用于癌症免疫治疗的PD-1和PD-L1检查点信号抑制:机制、联合应用及临床结果
Front Pharmacol. 2017 Aug 23;8:561. doi: 10.3389/fphar.2017.00561. eCollection 2017.
8
PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma.在接受统一治疗的经典型霍奇金淋巴瘤患者中,程序性死亡受体配体1(PD-L1)表达与血管内皮生长因子(VEGF)及微血管密度相关。
Ann Hematol. 2017 Nov;96(11):1883-1890. doi: 10.1007/s00277-017-3115-6. Epub 2017 Aug 25.
9
Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway.岩藻依聚糖对前列腺癌的抗肿瘤和抗血管生成作用:可能通过JAK-STAT3信号通路
BMC Complement Altern Med. 2017 Aug 1;17(1):378. doi: 10.1186/s12906-017-1885-y.
10
Cytotoxic Effects of Sarcophyton sp. Soft Corals-Is There a Correlation to Their NMR Fingerprints?肉芝软珊瑚的细胞毒性作用——与它们的核磁共振指纹图谱是否存在关联?
Mar Drugs. 2017 Jul 4;15(7):211. doi: 10.3390/md15070211.